Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Capital Markets Day

28 Jan 2021 07:00

RNS Number : 1216N
Science in Sport PLC
28 January 2021
 

28 January 2021

SCIENCE IN SPORT PLC

("Company" or "Group")

Capital Markets Day

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, will today hold a virtual Capital Markets Day for institutional investors at 14:00 (GMT) with a focus on the Group's strategy.

The event will be hosted by Stephen Moon, CEO, James Simpson, CFO and Ashley Read, COO.

No new material disclosures will be made during the event and all presentation materials will be made available at https://www.sisplc.com/.

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

 

Notes to Editors

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium active-nutrition brand targeting the gym lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands are sold internationally through our own phd.com and scienceinsport.com digital platform, together with third-party online sites including Amazon and Tmall. We have extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market currently estimated at approximately 11 billion worldwide.

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since its launch in 2005. The range now comprises powders, bars and supplements including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading fitness influencers Ross Edgley and Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and recovery. SiS is the official sports nutrition supplier to many professional teams and organisations including INEOS Grenadiers Cycling Team, Team INEOS UK (America's Cup Team) and Manchester United Football Club. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is Performance Research Partner to the English Football Association.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit phd.com and scienceinsport.com  

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXFXALAFEFA
Date   Source Headline
29th Jul 202412:05 pmRNSTR-1: Notification of Major Holdings
29th Jul 202410:02 amRNSTR-1: Notification of Major Holdings
26th Jul 202411:52 amRNSTR-1: Notification of Major Holdings
24th Jul 202412:43 pmRNSResult of General Meeting and Total Voting Rights
16th Jul 202410:26 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:11 amRNSTR-1: Notification of Major Holdings
16th Jul 202410:10 amRNSTR-1: Notification of Major Holdings
9th Jul 20249:20 amRNSDirector/PDMR Shareholding
8th Jul 20242:16 pmRNSDirector/PDMR Shareholding
8th Jul 20241:36 pmRNSPosting of Circular and notice of General Meeting
8th Jul 20247:00 amRNSResult of the Retail Offer
5th Jul 202412:38 pmRNSDirector/PDMR Shareholding
5th Jul 20247:01 amRNSManagement Incentive Plan
5th Jul 20247:00 amRNSResult of Placing and director dealings
4th Jul 20245:10 pmRNSRetail Offer for up to £0.5 million
4th Jul 20245:04 pmRNSProposed Placing and Retail Offer
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20243:42 pmRNSAnnual Report and Notice of Annual General Meeting
28th Jun 20247:00 amRNSFinal Results for the Year Ended 31 December 2023
28th Jun 20247:00 amRNSHalf Year Trading Update and Board Changes
12th Jun 20247:00 amRNSNotice of Results
21st May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
20th May 20247:00 amRNSNotification of Major Holdings
15th May 202410:35 amRNSNotification of Major Holdings
14th May 202411:20 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.